Close

Teva Pharma (TEVA) Tops Q1 EPS by 11c

April 30, 2015 7:04 AM EDT

Teva Pharma (NYSE: TEVA) reported Q1 EPS of $1.36, $0.11 better than the analyst estimate of $1.25. Revenue for the quarter came in at $5 billion versus the consensus estimate of $4.84 billion.

For earnings history and earnings-related data on Teva Pharma (TEVA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings